NO20024095L - Anestetiske formuleringer - Google Patents

Anestetiske formuleringer

Info

Publication number
NO20024095L
NO20024095L NO20024095A NO20024095A NO20024095L NO 20024095 L NO20024095 L NO 20024095L NO 20024095 A NO20024095 A NO 20024095A NO 20024095 A NO20024095 A NO 20024095A NO 20024095 L NO20024095 L NO 20024095L
Authority
NO
Norway
Prior art keywords
anesthetic formulations
propofol
preparations
anesthetic
formulations
Prior art date
Application number
NO20024095A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024095D0 (no
Inventor
James Du Mayne
John Meadows
Original Assignee
Maelor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Pharmaceuticals Ltd filed Critical Maelor Pharmaceuticals Ltd
Publication of NO20024095D0 publication Critical patent/NO20024095D0/no
Publication of NO20024095L publication Critical patent/NO20024095L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20024095A 2000-02-29 2002-08-28 Anestetiske formuleringer NO20024095L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0004841A GB2359747B (en) 2000-02-29 2000-02-29 Anaesthetic formulations
PCT/GB2001/000868 WO2001064187A2 (en) 2000-02-29 2001-02-28 Anaesthetic formulations

Publications (2)

Publication Number Publication Date
NO20024095D0 NO20024095D0 (no) 2002-08-28
NO20024095L true NO20024095L (no) 2002-10-23

Family

ID=9886669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024095A NO20024095L (no) 2000-02-29 2002-08-28 Anestetiske formuleringer

Country Status (21)

Country Link
US (2) US7166303B2 (zh)
EP (1) EP1259226B1 (zh)
JP (1) JP4215430B2 (zh)
KR (1) KR100652552B1 (zh)
CN (1) CN100376232C (zh)
AT (1) ATE324101T1 (zh)
AU (2) AU3580901A (zh)
BR (1) BR0108738A (zh)
CA (1) CA2401089C (zh)
CZ (1) CZ300790B6 (zh)
DE (1) DE60119082T2 (zh)
DK (1) DK1259226T3 (zh)
ES (1) ES2262628T3 (zh)
GB (1) GB2359747B (zh)
HU (1) HU226485B1 (zh)
IL (2) IL151311A0 (zh)
NO (1) NO20024095L (zh)
NZ (1) NZ520765A (zh)
RU (1) RU2250101C2 (zh)
WO (1) WO2001064187A2 (zh)
ZA (1) ZA200206233B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743436B1 (en) * 1999-06-21 2004-06-01 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
GB0120701D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
HUP0600241A2 (en) * 2002-04-08 2006-07-28 Mgi Gp Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
CA2494297C (en) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
GB0327390D0 (en) * 2003-11-25 2003-12-31 Pfizer Ltd Pharmaceutical formulations
CA2556185C (en) * 2004-02-13 2010-09-21 Bioavailability, Inc. A microemulsion preparation of high concentration propofol for anesthetic uses
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
JP5068750B2 (ja) * 2005-07-08 2012-11-07 フィジカ ファルマ プロポフオールを含む透明な薬学的水性マイクロエマルジョン及び製造方法
WO2007108505A1 (ja) * 2006-03-22 2007-09-27 Chugai Seiyaku Kabushiki Kaisha エリスロポエチン溶液製剤
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
KR20090080046A (ko) * 2006-09-22 2009-07-23 라보팜 인코포레이트 ｐＨ 표적화된 약물 운반용 조성물 및 방법
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
WO2010088924A1 (en) * 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
US8945627B2 (en) * 2011-05-05 2015-02-03 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
WO2016004369A1 (en) 2014-07-02 2016-01-07 The Research Foundation For The State University Of New York Surfactant-stripped micelle compositions with high cargo to surfactant ratio

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
DK1105096T3 (da) * 1998-08-19 2004-03-08 Skyepharma Canada Inc Injicerbare vandige propofoldispersioner
US6743436B1 (en) * 1999-06-21 2004-06-01 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations

Also Published As

Publication number Publication date
CN100376232C (zh) 2008-03-26
WO2001064187A3 (en) 2002-01-03
CA2401089C (en) 2011-01-18
HUP0300125A2 (hu) 2003-07-28
ATE324101T1 (de) 2006-05-15
BR0108738A (pt) 2002-12-17
US20070122467A1 (en) 2007-05-31
RU2002123180A (ru) 2004-03-20
ZA200206233B (en) 2003-11-05
WO2001064187A2 (en) 2001-09-07
NO20024095D0 (no) 2002-08-28
EP1259226B1 (en) 2006-04-26
CA2401089A1 (en) 2001-09-07
DK1259226T3 (da) 2006-08-21
HUP0300125A3 (en) 2003-09-29
CZ20022914A3 (cs) 2003-01-15
ES2262628T3 (es) 2006-12-01
KR20030011781A (ko) 2003-02-11
KR100652552B1 (ko) 2006-11-30
HU226485B1 (en) 2009-03-02
US20030138489A1 (en) 2003-07-24
NZ520765A (en) 2003-07-25
GB0004841D0 (en) 2000-04-19
IL151311A0 (en) 2003-04-10
DE60119082T2 (de) 2006-11-30
RU2250101C2 (ru) 2005-04-20
GB2359747B (en) 2002-04-24
JP4215430B2 (ja) 2009-01-28
GB2359747A (en) 2001-09-05
IL151311A (en) 2007-10-31
AU3580901A (en) 2001-09-12
CZ300790B6 (cs) 2009-08-12
WO2001064187B1 (en) 2002-03-07
EP1259226A2 (en) 2002-11-27
DE60119082D1 (de) 2006-06-01
AU2001235809B2 (en) 2004-08-05
US7166303B2 (en) 2007-01-23
CN1416337A (zh) 2003-05-07
JP2003525231A (ja) 2003-08-26
WO2001064187A8 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
DK1259226T3 (da) Anæstetiske formuleringer
CR7614A (es) Preparaciones de insulina acida con estabilidad mejorada
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
PT977562E (pt) Metodos e composicoes para administracao de taxanos
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
ATE398997T1 (de) Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
ATE218364T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
BR0107869A (pt) Composições farmacêuticas eletrogiradas
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
EE9900612A (et) Inimese papilloomiviiruse stabiliseeritud preparaadid
SE9800729L (sv) Ny topikal formulering I
NO20043001D0 (no) Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
DE60207266D1 (de) Anaesthetische propofol zubereitungen
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
NZ521533A (en) Veterinary compositions for the treatment of parasitic diseases containing rafoxanide
ATE380543T1 (de) Stabilisierung von festen schilddrüsenhormonzusammensetzungen
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
ATE301453T1 (de) Injizierbare arzneiformulierungen von partricin derivaten
ATE461711T1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
CL2015003413A1 (es) Formulación estable que comprende la proteína iduronato-2-sulfatasa y un tensoactico de polisorbato; contenedor que comprende dicha formulación; uso de dicha formulación para tratar síndrome de hunters.
RU97113620A (ru) Ранозаживляющая мазь "эпофен"

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application